Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the RNA-Based Therapeutics and Vaccines industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
MiRagen Therapeutics
Arrowhead Pharmaceuticals
Arbutus Biopharma
Regulus Therapeutics
Moderna Therapeutics
Roche
CureVac
Alnylam Pharmaceuticals
Dicerna Pharmaceuticals
Sylentis
Quark Pharmaceuticals
BioNTech
Marina Biotech
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
RNA-Based Therapeutics
RNA-Based Vaccines
Application:
Oncology
Immunology
Ophthalmology
Cardiovascular Diseases
Infectious Diseases
Genetic Diseases
Others
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 RNA-Based Therapeutics and Vaccines Industry Overview
-
1.1.1 RNA-Based Therapeutics and Vaccines Market Scope and Market Segments
-
1.1.2 RNA-Based Therapeutics and Vaccines Industry Characteristics
-
1.1.3 Global and China RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China RNA-Based Therapeutics and Vaccines Production Value and Growth Rate (2017-2028)
-
1.2 Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 RNA-Based Therapeutics
-
1.2.2 RNA-Based Vaccines
-
1.3 Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Oncology
-
1.3.2 Immunology
-
1.3.3 Ophthalmology
-
1.3.4 Cardiovascular Diseases
-
1.3.5 Infectious Diseases
-
1.3.6 Genetic Diseases
-
1.3.7 Others
-
1.4 Market Analysis by Region
-
1.4.1 North America RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global RNA-Based Therapeutics and Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global RNA-Based Therapeutics and Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China RNA-Based Therapeutics and Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China RNA-Based Therapeutics and Vaccines Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global RNA-Based Therapeutics and Vaccines Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 RNA-Based Therapeutics and Vaccines Industry Porter's Five Forces Model Analysis
-
2.2.3 RNA-Based Therapeutics and Vaccines Industry PEST Analysis
-
2.3 RNA-Based Therapeutics and Vaccines Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 RNA-Based Therapeutics and Vaccines Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on RNA-Based Therapeutics and Vaccines Industry
Chapter 3 Global and China RNA-Based Therapeutics and Vaccines Market, by Manufacturer
-
3.1 Global and China RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China RNA-Based Therapeutics and Vaccines Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China RNA-Based Therapeutics and Vaccines Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China RNA-Based Therapeutics and Vaccines Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China RNA-Based Therapeutics and Vaccines Market Top 3 Players
Chapter 4 Global and China RNA-Based Therapeutics and Vaccines Market, by Type (2017-2028)
-
4.1 RNA-Based Therapeutics and Vaccines Market Trend, by Type
-
4.2 Global RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global RNA-Based Therapeutics and Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global RNA-Based Therapeutics and Vaccines Price Trend, by Type (2017-2028)
-
4.3 China RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China RNA-Based Therapeutics and Vaccines Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China RNA-Based Therapeutics and Vaccines Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China RNA-Based Therapeutics and Vaccines Price Trend, by Type (2017-2028)
Chapter 5 Global and China RNA-Based Therapeutics and Vaccines Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global RNA-Based Therapeutics and Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global RNA-Based Therapeutics and Vaccines Sales Value and Market Share, by Application (2017-2028)
-
5.3 China RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China RNA-Based Therapeutics and Vaccines Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China RNA-Based Therapeutics and Vaccines Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.2 North America RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America RNA-Based Therapeutics and Vaccines Market Analysis
-
7.1 North America RNA-Based Therapeutics and Vaccines Market, by Type
-
7.2 North America RNA-Based Therapeutics and Vaccines Market, by Application
-
7.3 North America RNA-Based Therapeutics and Vaccines Market Analysis and Forecast, by Country
-
7.3.1 United States RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe RNA-Based Therapeutics and Vaccines Market Analysis
-
8.1 Europe RNA-Based Therapeutics and Vaccines Market, by Type
-
8.2 Europe RNA-Based Therapeutics and Vaccines Market, by Application
-
8.3 Europe RNA-Based Therapeutics and Vaccines Market Analysis and Forecast, by Country
-
8.3.1 Germany RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC RNA-Based Therapeutics and Vaccines Market Analysis
-
9.1 APAC RNA-Based Therapeutics and Vaccines Market, by Type
-
9.2 APAC RNA-Based Therapeutics and Vaccines Market, by Application
-
9.3 APAC RNA-Based Therapeutics and Vaccines Market Analysis and Forecast, by Country
-
9.3.1 China RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Market Analysis
-
10.1 Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Market, by Type
-
10.2 Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Market, by Application
-
10.3 Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina RNA-Based Therapeutics and Vaccines Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China RNA-Based Therapeutics and Vaccines Company Profiles
-
11.1 MiRagen Therapeutics
-
11.1.1 MiRagen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.1.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Arrowhead Pharmaceuticals
-
11.2.1 Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.2.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Arbutus Biopharma
-
11.3.1 Arbutus Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.3.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Regulus Therapeutics
-
11.4.1 Regulus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.4.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Moderna Therapeutics
-
11.5.1 Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.5.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Roche
-
11.6.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Roche RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.6.3 Roche RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 CureVac
-
11.7.1 CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 CureVac RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.7.3 CureVac RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Alnylam Pharmaceuticals
-
11.8.1 Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.8.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Dicerna Pharmaceuticals
-
11.9.1 Dicerna Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.9.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Sylentis
-
11.10.1 Sylentis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Sylentis RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.10.3 Sylentis RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Quark Pharmaceuticals
-
11.11.1 Quark Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 BioNTech
-
11.12.1 BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 BioNTech RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.12.3 BioNTech RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Marina Biotech
-
11.13.1 Marina Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Marina Biotech RNA-Based Therapeutics and Vaccines Product Profiles, Application and Specification
-
11.13.3 Marina Biotech RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 RNA-Based Therapeutics and Vaccines Industry Investment Prospect and Risk Assessment
-
12.1 RNA-Based Therapeutics and Vaccines Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 RNA-Based Therapeutics and Vaccines Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Production Value and Growth Rate (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Production Value and Growth Rate (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Therapeutics (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of RNA-Based Vaccines (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Oncology (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Immunology (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Ophthalmology (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Cardiovascular Diseases (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Infectious Diseases (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Genetic Diseases (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate of Others (2017-2028)
-
Figure North America RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China RNA-Based Therapeutics and Vaccines Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China RNA-Based Therapeutics and Vaccines Sales Value, by Manufacturer (2021&2022)
-
Table Global and China RNA-Based Therapeutics and Vaccines Market Share, by Manufacturer (2021&2022)
-
Figure Global and China RNA-Based Therapeutics and Vaccines Market Share, by Manufacturer in 2021
-
Figure Global and China RNA-Based Therapeutics and Vaccines Market Share, by Manufacturer in 2022
-
Table Global RNA-Based Therapeutics and Vaccines Sales Volume, by Type (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Sales Value, by Type (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Sales Value Share, by Type (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Price Trend, by Type (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Volume, by Type (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Value, by Type (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Value Share, by Type (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Price Trend, by Type (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Sales Volume, by Application (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Sales Value, by Application (2017-2028)
-
Table Global RNA-Based Therapeutics and Vaccines Sales Value Share, by Application (2017-2028)
-
Figure Global RNA-Based Therapeutics and Vaccines Sales Value Share, by Application (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Volume, by Application (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Value, by Application (2017-2028)
-
Table China RNA-Based Therapeutics and Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Sales Value Share, by Application (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure North America RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Europe RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure APAC RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Production, Import, Consumption and Export (2017-2022)
-
Table North America RNA-Based Therapeutics and Vaccines Sales Volume, by Type (2017-2028)
-
Table North America RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure North America RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Table North America RNA-Based Therapeutics and Vaccines Sales Volume, by Application (2017-2028)
-
Table North America RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure North America RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure United States RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure United States RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Canada RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Canada RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Mexico RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Europe RNA-Based Therapeutics and Vaccines Sales Volume, by Type (2017-2028)
-
Table Europe RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Europe RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Europe RNA-Based Therapeutics and Vaccines Sales Volume, by Application (2017-2028)
-
Table Europe RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Europe RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Germany RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Germany RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure UK RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure UK RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure France RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure France RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Italy RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Italy RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Spain RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Spain RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Belgium RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Poland RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Poland RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Russia RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Russia RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Turkey RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Table APAC RNA-Based Therapeutics and Vaccines Sales Volume, by Type (2017-2028)
-
Table APAC RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure APAC RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Table APAC RNA-Based Therapeutics and Vaccines Sales Volume, by Application (2017-2028)
-
Table APAC RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure APAC RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure China RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Japan RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Japan RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure India RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure India RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Korea RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa RNA-Based Therapeutics and Vaccines Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Brazil RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure South Africa RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Figure Argentina RNA-Based Therapeutics and Vaccines Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina RNA-Based Therapeutics and Vaccines Sales Value and Growth Rate (2017-2028)
-
Table MiRagen Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table MiRagen Therapeutics Product Profiles, Application and Specification
-
Table MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Arrowhead Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arrowhead Pharmaceuticals Product Profiles, Application and Specification
-
Table Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Arbutus Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Arbutus Biopharma Product Profiles, Application and Specification
-
Table Arbutus Biopharma RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Regulus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Regulus Therapeutics Product Profiles, Application and Specification
-
Table Regulus Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Moderna Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Moderna Therapeutics Product Profiles, Application and Specification
-
Table Moderna Therapeutics RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CureVac Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CureVac Product Profiles, Application and Specification
-
Table CureVac RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Alnylam Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Alnylam Pharmaceuticals Product Profiles, Application and Specification
-
Table Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dicerna Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dicerna Pharmaceuticals Product Profiles, Application and Specification
-
Table Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sylentis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sylentis Product Profiles, Application and Specification
-
Table Sylentis RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Quark Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Quark Pharmaceuticals Product Profiles, Application and Specification
-
Table Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table BioNTech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table BioNTech Product Profiles, Application and Specification
-
Table BioNTech RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Marina Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Marina Biotech Product Profiles, Application and Specification
-
Table Marina Biotech RNA-Based Therapeutics and Vaccines Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
